| Literature DB >> 34782584 |
Melody N Mickens1, Paul Perrin2, Jacob A Goldsmith3, Refka E Khalil3, William E Carter Iii4, Ashraf S Gorgey5.
Abstract
The objective of the current work was to examine the relationships between quality of life (QOL) domains in persons with spinal cord injury (SCI) and their levels of weekly leisure-time physical activity (LTPA), anthropometric variables, and body composition variables. This exploratory cross-sectional study consisted of baseline data collected as part of a randomized clinical trial at a VA Medical Center and SCI center. A convenience sample of 36 community-dwelling persons with SCI participated in the current study. Outcome measures included the World Health Organization Quality of Life Short Form (WHOQOL-BREF), Leisure-Time Physical Activity Questionnaire for People with Spinal Cord Injury (LTPAQ-SCI), anthropomorphic measures (waist, hip, and abdominal circumference), and dual-energy x-ray absorptiometry (DXA) to quantify regional and total body composition. Multiple regression models suggested that engagement in LTPA accounted for 35.7% of the variance in physical health QOL, 33.5% in psychological QOL, 14.2% in social relationships QOL, and 38.2% in environmental QOL. Anthropometric measures accounted for 11.3%, 3.1%, 12.0%, and 6.7% of the variance in these QOL indices, respectively, and DXA indices accounted for 18.7%, 17.5%, 27.4%, and 21.9%. Within these models, the number of minutes of heavy LTPA per day uniquely predicted physical health QOL, the number of mild LTPA days per week uniquely predicted psychological QOL, and the amount of mild LTPA per day uniquely predicted environmental QOL. Bivariate analyses also suggested that android and trunk fat, as well as supine waist and abdominal circumferences, were positively associated with social relationships QOL. Encouraging individuals with SCI to engage in LTPA may robustly enhance multiple aspects of QOL while reducing the risk for cardiovascular and metabolic morbidities associated with SCI. Moreover, this may lead to a further understanding of how QOL may impact longitudinal intervention trials. The study protocol and procedures were reviewed and approved by the McGuire VA Research Institutional Review Board (IRB# 02152, approval date August 9, 2015; IRB# 02375, approval date May 2, 2018).Entities:
Keywords: anthropometrics; body composition; dual-energy-x-ray absorptiometry; exercise; physical activity; quality of life; spinal cord injury
Year: 2022 PMID: 34782584 PMCID: PMC8643047 DOI: 10.4103/1673-5374.327356
Source DB: PubMed Journal: Neural Regen Res ISSN: 1673-5374 Impact factor: 5.135
Physical and SCI characteristics of the participants enrolled in the current study
| Variable | |
|---|---|
| Sex | |
| Male | 29 (80.6) |
| Female | 7 (19.4) |
| Race/ethnicity | |
| White/European-American | 21 (58.3) |
| Black/African-American | 15 (41.7) |
| Injury classification | |
| Paraplegia | 23 (63.9) |
| Tetraplegia | 13 (36.1) |
| Level of Injury | |
| Cervical | 14 (38.9) |
| Thoracic | 21 (58.3) |
| Lumbar | 1 (2.8) |
| AIS Impairment Scale Classification | |
| A | 21 (58.3) |
| B | 9 (25.0) |
| C | 6 (16.7) |
| Age (yr) | 40.00±13.00 |
| Weight (kg) | 70.45±14.95 |
| Height (cm) | 174.25±9.10 |
| Body mass index (kg/m2) | 23.4±5.5 |
| Time since injury (yr) | 10.8±10.23 |
AIS: ASIA (American Spinal Injury Association) Impairment Scale.
STROBE Statement-Checklist of items that should be included in reports of cross-sectional studies
| Item No | Recommendation | |
|---|---|---|
|
| 1 | (a) Indicate the study’s design with a commonly used term in the title or the abstract |
|
| ||
| (b) Provide in the abstract an informative and balanced summary of what was done and what was found | ||
|
| ||
|
| ||
|
| ||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported |
|
| ||
| Objectives | 3 | State specific objectives, including any prespecified hypotheses |
|
| ||
|
| ||
|
| ||
| Study design | 4 | Present key elements of study design early in the paper |
|
| ||
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection |
|
| ||
| Participants | 6 | (a) Give the eligibility criteria, and the sources and methods of selection of participants |
|
| ||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable |
|
| ||
| Data sources/ measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group |
|
| ||
| Bias | 9 | Describe any efforts to address potential sources of bias |
|
| ||
| Study size | 10 | Explain how the study size was arrived at |
|
| ||
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why |
|
| ||
| Statistical methods | 12 | |
|
| ||
|
| ||
|
| ||
|
| ||
|
| ||
|
| ||
|
| ||
| Participants | 13* | (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed |
|
| ||
| (b) Give reasons for non-participation at each stage | ||
|
| ||
| (c) Consider use of a flow diagram | ||
|
| ||
| Descriptive data | 14* | (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders |
|
| ||
| (b) Indicate number of participants with missing data for each variable of interest | ||
|
| ||
| Outcome data | 15* | Report numbers of outcome events or summary measures |
|
| ||
| Main results | 16 | |
|
| ||
| (a) Report category boundaries when continuous variables were categorized | ||
|
| ||
| (b) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | ||
|
| ||
| Other analyses | 17 | Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses |
|
| ||
|
| ||
|
| ||
| Key results | 18 | Summarise key results with reference to study objectives |
|
| ||
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias |
|
| ||
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence |
|
| ||
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results |
|
| ||
|
| ||
|
| ||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based |
*Give information separately for exposed and unexposed groups.
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.
Descriptive statistics of predictors (anthropometrics, body composition parameters, and LTPA) and domains of QOL
| Variable category | Variable | Mean ± SD | Range | |
|---|---|---|---|---|
|
| ||||
| Min | Max | |||
| Anthropometrics | Sup waist Cir. (cm) | 82.5±13.9 | 59.80 | 110.20 |
| Sup Ab Cir. (cm) | 87.98±16.0 | 61.70 | 118.70 | |
| Supine hip Cir. (cm) | 90.10±14.15 | 57.90 | 118.90 | |
| DXA | Legs fat (g) | 6987.81±3397.33 | 2508.00 | 15563.00 |
| Legs lean (g) | 13104.83±2601.03 | 7974.00 | 18877.00 | |
| Trunk fat (g) | 12205.17±7506.79 | 1945.00 | 28288.00 | |
| Trunk lean (g) | 21630.47±3321.44 | 15382.00 | 27129.00 | |
| Android fat (g) | 2031.81±1474.40 | 216.00 | 5255.00 | |
| Android lean (g) | 3146.92±589.28 | 1767.00 | 4318.00 | |
| LTPA | Mild (d/wk) | 3.97±2.47 | 0 | 7.00 |
| Mild (min/d) | 109.36±114.88 | 0 | 480.00 | |
| Mod (d/wk) | 3.33±2.52 | 0 | 7.00 | |
| Mod (min/d) | 64.58±89.94 | 0 | 480.00 | |
| Heavy (d/wk) | 1.78±2.42 | 0 | 7.00 | |
| Heavy (min/d) | 39.86±52.16 | 0 | 180.00 | |
| QOL | Physical health | 14.63±2.81 | 9.14 | 18.86 |
| Psychological | 15.76±2.99 | 8.00 | 20.00 | |
| Social relationships | 13.78±3.23 | 4.00 | 18.67 | |
| Environment | 15.92±2.39 | 10.50 | 20.00 | |
Data are expressed as the mean ± SD. Ab: Abdominal; Cir: circumference; DXA: dual-energy x-ray absorptiometry; LTPA: leisure-time physical activity; Mod: moderate; QOL: quality of life; Sup: supine. QOL means the domain item average multiplied by 4.
Partial correlation matrix examining the primary predictors of the study (LTPA, anthropometrics, and body composition parameters) and domains of quality of life using age and TSI as control variables
| Variable | Physical health | Psychological | ||
|---|---|---|---|---|
| Control variable | Age | TSI | Age | TSI |
| LTPA | ||||
| Mild (d/wk) | 0.27 | 0.27 |
|
|
| Mild (min/d) |
|
| 0.29 | 0.26 |
| Mod (d/wk) | 0.09 | 0.09 | 0.22 | 0.22 |
| Mod (min/d) | 0.25 | 0.26 | 0.33 | 0.28 |
| Heavy (d/wk) | 0.12 | 0.12 | 0.07 | 0.06 |
| Heavy (min/d) | 0.45 |
| 0.06 | 0.03 |
| DXA | ||||
| Legs fat (g) | 0.17 | 0.14 | –0.03 | –0.02 |
| Legs lean (g) | 0.26 | 0.25 | 0.13 | 0.16 |
| Trunk fat (g) | 0.08 | 0.03 | –0.02 | –0.02 |
| Trunk lean (g) | –0.02 | –0.03 | –0.05 | –0.04 |
| Andro fat (g) | 0.13 | 0.07 | 0.04 | 0.02 |
| Andro lean (g) | –0.02 | –0.04 | –0.03 | –0.04 |
| Anthro | ||||
| Sup waist Cir. (cm) | 0.06 | 0.002 | –0.06 | –0.04 |
| Sup hip Cir. (cm) | –0.12 | –0.15 | –0.12 | –0.11 |
| Sup Ab Cir. (cm) | 0.25 | 0.17 | –0.05 | –0.04 |
|
| ||||
|
|
|
| ||
|
| ||||
| Control variable | Age | TSI | Age | TSI |
| LTPA | ||||
| Mild (d/wk) | 0.11 | 0.09 | 0.21 | 0.22 |
| Mild (min/d) | 0.1 | 0.05 |
|
|
| Mod (d/wk) | 0.03 | 0.03 | –0.18 | –0.18 |
| Mod (min/d) | 0.26 | 0.21 | 0.29 | 0.23 |
| Heavy (d/wk) | 0.22 | 0.22 | 0.02 | –0.02 |
| Heavy (min/d) | 0.02 | –0.02 | 0.13 | 0.14 |
| DXA | ||||
| Legs fat (g) | 0.19 | 0.23 | 0.23 | 0.11 |
| Legs lean (g) | 0.06 | 0.09 | 0.18 | 0.15 |
| Trunk fat (g) | 0.29 | 0.32 | 0.07 | –0.12 |
| Trunk lean (g) | –0.07 | –0.04 | –0.16 | –0.19 |
| Andro fat (g) |
|
| 0.14 | –0.07 |
| Andro lean (g) | 0.06 | 0.08 | –0.09 | –0.15 |
| Anthro | ||||
| Sup waist Cir. (cm) | 0.27 | 0.31 | 0.03 | –0.15 |
| Sup hip Cir. (cm) | 0.21 | 0.24 | –0.04 | –0.16 |
| Sup Ab Cir. (cm) | 0.17 | 0.22 | 0.15 | –0.03 |
*P < 0.05, **P < 0.01. Ab: Abdominal; Andro: android; Anthro: anthropometric; Cir: circumference; DXA: dual-energy X-ray absorptiometry; LTPA: leisure-time physical activity; Mod: moderate; Sup: supine; TSI: time since injury.
Multiple regression analyses with the study’s primary predictors (LTPA, anthropometrics, and body composition parameters) and domains of QOL
| Predictor variable | Physical health | Psychological | Social relationships | Environment |
|---|---|---|---|---|
| Predictors: LTPA | ||||
| Mild (d/wk) | 0.20 |
| 0.08 | 0.36 |
| Mild (min/d) | 0.26 | 0.14 | 0.02 |
|
| Mod (d/wk) | –0.24 | –0.07 | –0.05 |
|
| Mod (min/d) | 0.11 | 0.29 | 0.25 | 0.19 |
| Heavy (d/wk) | –0.26 | –0.07 | 0.26 | –0.24 |
| Heavy (min/d) |
| –0.16 | –0.22 | 0.21 |
| Model R2 |
| 0.34 | 0.14 |
|
| Predictors: Anthropometrics | ||||
| Supine waist Cir. (cm) | –0.71 | 0.65 | 0.73 | –0.88 |
| Supine hip Cir. (cm) | 0.08 | –0.42 | –0.16 | 0.26 |
| Supine Ab Cir. (cm) | 0.74 | –0.39 | –0.32 | 0.63 |
| Model R2 | 0.11 | 0.03 | 0.12 | 0.07 |
| Predictors: DXA | ||||
| Legs fat (g) | 0.12 | –0.18 | –0.17 | 0.19 |
| Legs lean (g) | 0.37 | 0.19 | 0.05 | 0.32 |
| Trunk fat (g) | –1.72 | –2.45 | –1.56 | –2.02 |
| Trunk lean (g) | 0.29 | 0.09 | –0.35 | –0.075 |
| Android fat (g) | 1.78 | 2.72 | 2.06 | 1.87 |
| Android lean (g) | –0.57 | –0.28 | 0.21 | –0.23 |
| Model R2 | 0.19 | 0.18 | 0.27 | 0.22 |
*P < 0.05, **P < 0.01. All regression weights are standardized betas. Ab: Abdominal; Cir: circumference; LTPA: leisure-time physical activity; Mod: moderate; QOL: quality of life.
Multiple regression analyses with the study’s primary predictors (LTPA, anthropometrics, and body composition parameters) and modules of quality of life
| Predictor variable | Physical health | Psychological | Social relationships | Environment | ||||
|---|---|---|---|---|---|---|---|---|
| Mild (d/wk) | 0.233 | –0.230 to 0.696 |
| 0.067 to 1.069 | 0.099 | –0.515 to 0.714 | 0.347 | –0.039 to 0.733 |
| Mild (min/d) | 0.006 | –0.002 to 0.015 | 0.004 | –0.006 to 0.013 | 0.000 | –0.001 to 0.012 |
| 0.000 to 0.014 |
| Mod (d/wk) | –0.265 | –0.715 to 0.186 | –0.087 | –0.574 to 0.401 | –0.065 | –0.633 to 0.534 |
| –0.871 to –0.120 |
| Mod (min/d) | 0.004 | –0.007 to 0.14 | 0.010 | –0.002 to 0.021 | 0.009 | –0.005 to 0.023 | 0.005 | –0.004 to 0.014 |
| Heavy (d/wk) | –0.306 | –0.750 to 0.138 | –0.087 | –0.567 to 0.394 | 0.342 | –0.247 to 0.932 | –0.233 | –0.603 to 0.137 |
| Heavy (min/d) |
| 0.007 to 0.048 | –0.009 | –0.031 to 0.013 | –0.014 | –0.041 to 0.013 | 0.010 | –0.007 to 0.027 |
| Adjusted R2 |
| 0.197 | –0.036 |
| ||||
| Sup waist Cir. (cm) | –0.136 | –0.428 to 0.156 | 0.137 | –0.199 to 0.473 | 0.145 | –0.157 to 0.447 | –0.141 | –0.393 to 0.111 |
| Sup hip Cir. (cm) | 0.016 | –0.149 to 0.181 | –0.089 | –0.279 to 0.100 | –0.033 | –0.203 to 0.138 | 0.042 | –0.100 to 0.184 |
| Sup Ab Cir. (cm) | 0.123 | –0.057 to 0.303 | –0.072 | –0.279 to 0.134 | –0.055 | –0.241 to 0.131 | 0.087 | –0.068 to 0.243 |
| Adjusted R2 | 0.021 | –0.069 | 0.029 | –0.029 | ||||
| Leg fat (g) | 9.66E-05 | 0.000 to 0.001 | 0 | –0.001 to 0.000 | 0.000 | –0.001 to 0.000 | 0.000 | 0.000 to 0.001 |
| Leg lean (g) | 0 | 0.000 to 0.001 | 0 | 0.000 to 0.001 | 5.71E-05 | –0.001 to 0.001 | 0.000 | 0.000 to 0.001 |
| Trunk fat (g) | –0.001 | –0.002 to 0.001 | –0.001 | –0.002 to 0.000 | –0.001 | –0.002 to 0.001 | –0.001 | –0.002 to 0.000 |
| Trunk lean (g) | 0 | –0.001 to 0.001 | 8.301E-5 | –0.001 to 0.001 | 0.000 | –0.001 to 0.001 | –5.367E-5 | –0.001 to 0.001 |
| Android fat (g) | 0.003 | –0.002 to 0.009 | 0.006 | –0.001 to 0.012 | 0.005 | –0.002 to 0.011 | 0.003 | –0.002 to 0.008 |
| Android lean (g) | –0.003 | –0.008 to 0.002 | –0.001 | –0.007 to 0.004 | 0.001 | –0.004 to 0.006 | –0.001 | –0.005 to 0.003 |
| Adjusted R2 | 0.019 | 0.004 | 0.124 | 0.058 | ||||
*P < 0.05, **P < 0.01. All regression weights are b weights with 95% confidence intervals. Ab: Abdominal; Cir: circumference; Mod: moderate; Sup: supine.
Spearman’s rho correlation matrix between the study’s primary predictors (LTPA, anthropometrics, and body composition parameters) and domains of QOL
| Variable | Physical health | Psychological | Social relationships | Environment |
|---|---|---|---|---|
| LTPA | ||||
| Mild (d/wk) | 0.28 |
| 0.1 | 0.25 |
| Mild (min/d) |
| 0.25 | 0.11 |
|
| Mod (d/wk) | 0.17 | 0.23 | 0.02 | –0.13 |
| Mod (min/d) | 0.23 | 0.32 | 0.19 | 0.20 |
| Heavy (d/wk) | 0.29 | 0.18 | 0.26 | 0.08 |
| Heavy (min/d) |
| 0.18 | 0.06 | 0.13 |
| DXA | ||||
| Legs fat (g) | 0.05 | –0.1 | 0.26 | 0.06 |
| Legs lean (g) | 0.17 | 0.08 | 0.02 | 0.10 |
| Trunk fat (g) | –0.04 | –0.03 |
| –0.04 |
| Trunk lean (g) | –0.08 | –0.04 | –0.05 | –0.19 |
| Android fat (g) | –0.02 | –0.007 |
| –0.02 |
| Android lean (g) | –0.06 | –0.02 | 0.05 | –0.11 |
| Anthro | ||||
| Sup waist Cir. (cm) | –0.04 | –0.07 |
| –0.08 |
| Sup hip Cir. (cm) | –0.12 | –0.12 | 0.24 | 0 |
| Sup Ab Cir. (cm) | 0.17 | 0.02 |
| 0.04 |
*P < 0.05, **P < 0.01. Ab: Abdominal; Anthro: anthropometric; Cir: circumference; DXA: dual-energy x-ray absorptiometry; LTPA: leisure-time physical activity; Mod: moderate; Sup: supine.